# Achieve Life Sciences (ACHV) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/ACHV
## Company Profile
- Ticker: ACHV
- Exchange: NASDAQ
- Sector: Life Science Tools
- Location: United States
- Tags: Life Science Tools
## Stock Data
- Close: 6.66 USD
- Market cap: 516375056.71000004 USD
- Last updated: 2026-08-05
## Business Overview
### Nicotine Dependence Company
Achieve Life Sciences develops cytisinicline as a treatment for nicotine dependence and smoking cessation.
### Cytisinicline
Cytisinicline is a plant-derived partial agonist of the nicotinic acetylcholine receptor and is intended as a shorter-course alternative to existing prescription therapies.
### Phase 3 Evidence
The ORCA-2 and ORCA-3 studies demonstrated higher continuous abstinence rates than placebo, including in participants previously treated with varenicline or bupropion.
### Manufacturing Transition
Achieve is transitioning manufacturing after FDA inspection findings at a prior third-party facility affected the current NDA review.
## Why The Stock Is Moving

As of Aug 5, 2026, ACHV closed up 2.94% at $6.66. No new same-company headline was identified in the current news window.

## Future Catalysts

- Near-term attention for Achieve Life Sciences is likely to stay on ORCA-V2. The current setup is really about “If approved, cytisinicline would be the first new FDA-approved smoking cessation therapy in more than two decades, and could also be the first ever for vaping cessation. That is where the next meaningful signal is most likely to come from.

## Drug Assets

- cytisinicline

## Recent News
- 2026-08-03 12:30 EST — [Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-ronald-dadino-and-gloria-cosgrove-to-lead-cmc-sup-fde99cb7) — Source: Achieve Life Sciences
- 2026-07-31 12:30 EST — [Achieve Life Sciences Announced Granting of New Hire Inducement Awards](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-announced-granting-of-new-hire-inducement-awards-925196f6) — Source: Achieve Life Sciences
- 2026-06-29 12:30 EST — [Achieve Life Sciences Joins Russell 2000® Index](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-joins-russell-2000-index-26eba5ff) — Source: Achieve Life Sciences
- 2026-06-22 12:30 EST — [Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-receives-complete-response-letter-from-fda-for-cytisinicli-673c44de) — Source: Achieve Life Sciences
- 2026-06-02 12:30 EST — [Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-jeffrey-farrow-and-reid-waldman-md-to-board-of-directors) — Source: Achieve Life Sciences